PATIENT INFORMATION LEAFLET
Qudix 200 mg Film-Coated Tablets EFG
Quetiapine
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Qudix contains a substance called quetiapina. It belongs to a group of medications called antipsychotics. Qudix may be used to treat various diseases, such as:
Your doctor may continue prescribing Qudix even when you feel better.
Do not take Qudix if the above applies to you. If you have any doubts, consult your doctor or pharmacist before taking Qudix.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Qudix if:
Inform your doctor immediately if after taking Qudix you experience any of the following:Qudixand the following symptoms::
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
• Fever, flu-like symptoms, sore throat, or any other infection, as it could be a consequence of very low white blood cell counts and require discontinuation of quetiapine treatment and/or additional treatment.
• Constipation with persistent abdominal pain, or constipation that has not responded to treatment, as it may lead to a more severe intestinal blockage.
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to take effect, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information obtained from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Qudix should not be used in children and adolescents under 18 years of age.
Use of Qudix with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Qudix if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Qudix with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication. Do not take Qudix during pregnancy, unless you have consulted your doctor. Do not use Qudix if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborn babies of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
These tablets may make you feel drowsy. Do not drive or operate tools or machinery until you know how the tablets affect you.
Qudix contains lactose
If your doctor has told you that you have a lactose intolerance, consult them before taking this medication.
Effect on drug detection tests in urine
If you are undergoing a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and needs, but will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Qudix should not be used in children and adolescents under 18 years of age.
If you take more Qudix than you should
If you take more Qudix than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring the Qudix tablets with you.
You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Qudix
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed tablet.
If you interrupt treatment with Qudix
If you stop taking Qudix abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from available data)
The class of medicines to which Qudix belongs can cause serious heart rhythm problems that may be life-threatening in severe cases.
Some side effects are only seen when blood tests are done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased numbers of certain types of blood cells, decreased red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium levels in the blood, and increased levels of prolactin hormone in the blood. Elevated levels of prolactin hormone may, in rare cases, lead to:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects(may affect more than 1 in 10 people):
de leche.
Common side effects (may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE drop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Qudix
The active ingredient is quetiapine. The tablets contain 200 mg of quetiapine (as quetiapine hemifumarate).
The other components are:
Tablet core: lactose monohydrate (lactose), microcrystalline cellulose, povidone, sodium carboxymethyl starch (Type A) (potato starch), glycerol dibehenate, anhydrous colloidal silica, and magnesium stearate.
Coating:lactose monohydrate (lactose), hypromellose, titanium dioxide (E171), and macrogol 4000.
Appearance of Qudix and contents of the packaging
The tablets are round, biconvex, scored on one face, and white in color. The tablet can be divided into equal doses.
They are presented in packs of 60 tablets.
Holder of the marketing authorization and manufacturer responsible
Holder of the marketing authorization
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 – 2nd floor
28023 Aravaca – Madrid
Manufacturer responsible
Neuraxpharm Pharmaceuticals, S.L.
Avda. de Barcelona, 69
08970 Sant Joan Despí - Barcelona
Date of the last review of this leaflet:June 2024.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.